For research use only. Not for therapeutic Use.
<span style="color:#000000;"><span style="font-family:arial,helvetica,sans-serif;"><span style="font-size:12px;">Tributyrin (CAS 60-01-5), also known as NSC661583, is a histone deacetylase (HDAC) inhibitor potentially for the treatment of solid tumors. It is <span style="font-variant-ligatures: normal; orphans: 2; widows: 2;">a triglyceride prodrug of </span><span style="font-variant-ligatures: normal; orphans: 2; widows: 2;">butyric acid with potential antineoplastic activity.</span></span></span></span>
Catalog Number | R027549 |
CAS Number | 60-01-5 |
Synonyms | Glyceryl Tributyrate; Butyrin; Butyryl triglyceride; Glycerin tributyrate; Glycerol tributanoate; Glycerol tributyrate; Glyceroltributyrin; Glyceryl tributanoate; Glyceryl tributyrate; NSC 661583; Tri-n-butyrin; Tributanoin; Tributin; Tributyroin; Tr |
Molecular Formula | C15H26O6 |
Purity | ≥95% |
Target | Apoptosis |
Storage | -20°C |
Overview of Clinical Research | <span style="color:#000000;"><span style="font-size:12px;">Tributyrin is a cell differentiation stimulant. The <span style="font-family: "Helvetica Neue", Helvetica, Arial, sans-serif; font-variant-ligatures: normal; orphans: 2; widows: 2;">Phase-I clinical trials for Solid tumours in USA (PO) started in 1998.</span></span></span> |
IUPAC Name | 2,3-di(butanoyloxy)propyl butanoate |
InChI | InChI=1S/C15H26O6/c1-4-7-13(16)19-10-12(21-15(18)9-6-3)11-20-14(17)8-5-2/h12H,4-11H2,1-3H3 |
InChIKey | UYXTWWCETRIEDR-UHFFFAOYSA-N |
SMILES | CCCC(=O)OCC(COC(=O)CCC)OC(=O)CCC |
Reference | <br /> |